HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William J Burlingham Selected Research

Collagen Type V (Type V Collagen)

12/2020NFATc3 regulation of collagen V expression contributes to cellular immunity to collagen type V and hypoxic pulmonary hypertension.
1/2018Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
1/2013Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
10/2010Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis.
8/2010Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome.
10/2008Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction.
3/2008Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.
11/2007IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William J Burlingham Research Topics

Disease

13Hypersensitivity (Allergy)
07/2015 - 10/2002
6Neoplasms (Cancer)
02/2020 - 11/2008
4Bronchiolitis Obliterans Syndrome
01/2018 - 08/2010
4Bronchiolitis
10/2010 - 11/2007
3Coronary Artery Disease (Coronary Atherosclerosis)
02/2016 - 10/2010
3Lymphoma (Lymphomas)
01/2015 - 01/2011
2Inflammation (Inflammations)
12/2020 - 12/2009
2Reperfusion Injury
12/2020 - 01/2018
2Infections
02/2020 - 03/2005
2Hyperplasia
11/2019 - 12/2015
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 11/2010
2Atherosclerosis
02/2016 - 10/2010
2Atherosclerotic Plaque (Atheroma)
02/2016 - 10/2010
2Fibrosis (Cirrhosis)
12/2015 - 09/2013
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2014 - 05/2005
2Idiopathic Pulmonary Fibrosis
01/2013 - 08/2010
2Epstein-Barr Virus Infections
08/2012 - 01/2011
2Vasculitis (Vasculitides)
12/2009 - 03/2008
2Primary Graft Dysfunction
10/2008 - 03/2008
1Pulmonary Hypertension
12/2020
1Hypertension (High Blood Pressure)
12/2020
1Hypoxia (Hypoxemia)
01/2019
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
01/2016
1Arteriosclerosis
12/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2015
1Alopecia (Baldness)
09/2013
1Necrosis
05/2013
1Edema (Dropsy)
05/2013
1Prostatic Neoplasms (Prostate Cancer)
12/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2010
1Disease Progression
10/2010
1Gastroesophageal Reflux (GERD)
08/2010
1Virus Diseases (Viral Diseases)
11/2008
1Residual Neoplasm
11/2008
1Human Influenza (Influenza)
05/2008
1Lung Diseases (Lung Disease)
03/2008
1Tetanus
11/2007
1Hepatitis B
09/2007
1Leukemia
05/2005

Drug/Important Bio-Agent (IBA)

8Collagen Type V (Type V Collagen)IBA
12/2020 - 11/2007
7AntigensIBA
07/2015 - 10/2002
3AutoantigensIBA
12/2020 - 10/2010
3InterleukinsIBA
02/2016 - 12/2009
2CollagenIBA
12/2020 - 02/2016
2Apolipoproteins E (ApoE)IBA
02/2016 - 10/2010
2Interleukin-10 (Interleukin 10)IBA
01/2016 - 11/2007
2Oncogene Proteins (Oncogene Protein)IBA
01/2015 - 08/2012
2Viral ProteinsIBA
08/2012 - 01/2011
2Isoantigens (Alloantigen)IBA
10/2010 - 05/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2009 - 03/2008
2Prostaglandins DIBA
10/2008 - 03/2008
2Transforming Growth Factor beta (TGF-beta)IBA
11/2007 - 05/2004
1Proteins (Proteins, Gene)FDA Link
12/2020
1transcription factor NF-AT c3IBA
12/2020
1Calcineurin InhibitorsIBA
02/2020
1RepSoxIBA
11/2019
1Becaplermin (PDGF-BB)FDA Link
11/2019
1Blood Substitutes (Artificial Blood)IBA
11/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1LigandsIBA
01/2018
1CytokinesIBA
01/2016
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
12/2015
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2015
1Peptides (Polypeptides)IBA
01/2014
1Biological ProductsIBA
01/2014
1VaccinesIBA
12/2012
1prostatic acid phosphataseIBA
12/2012
1A-Form DNA (A-DNA)IBA
12/2012
1Muromonab-CD3 (Muromonab CD3)FDA Link
08/2012
1lacto-N-fucopentaose IIIIBA
11/2010
1ApolipoproteinsIBA
10/2010
1Interferon-gamma (Interferon, gamma)IBA
12/2009
1Interleukin-17 (Interleukin 17)IBA
12/2009
1MonokinesIBA
03/2008
1Minor Histocompatibility AntigensIBA
05/2005
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2005
1InterferonsIBA
03/2005
1Metalloproteases (Metalloproteinases)IBA
03/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2004
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
10/2002

Therapy/Procedure

5Lung Transplantation
01/2013 - 09/2007
3Transplantation
01/2017 - 08/2009
3Immunotherapy
12/2012 - 11/2008
1Mucosal Administration
02/2016
1Hematopoietic Stem Cell Transplantation
01/2014
1Organ Transplantation
10/2013
1Heart Transplantation (Grafting, Heart)
01/2013
1Stem Cell Transplantation
05/2005
1Liver Transplantation
10/2002